{
  "claim": "Frawleys 1983 sworn account (Hercules 2,4,5-T essentially dioxin-free; no chloracne among Hercules workers 1961-1970; first learned of dioxin hazards Feb 1965 via Dow) is consistent with his own contemporaneous 1960s documents: the July 3 1963 Rowe letter and any 1965 memo.",
  "verdict": "partially-supported",
  "bestEvidence": "FOR (primary, independently fetched): V K Rowe of Dow to John P Frawley of Hercules, March 19 1965, convening a meeting on highly toxic dioxin impurities in 2,4,5-trichlorophenol (DocumentCloud doc 3253794; Poison Papers Bates B 1575) dates Frawleys documented dioxin contact to exactly the Feb-March 1965 window his affidavit names. LIMITING (primary): In re Agent Orange 565 F Supp 1263 (EDNY 1983) Hercules section, where the July 3 1963 Frawley-to-Rowe letter survives only as a court paraphrase of Frawleys own affidavit, plaintiffs read it oppositely, and no independent scan exists.",
  "reasoning": "CONSISTENT where testable: the one fully-readable contemporaneous Frawley document (March 19 1965 Rowe-to-Frawley letter) is real and falls inside the Feb-March 1965 first-knowledge window his affidavit names; the 1965 Hercules meeting-memo material (the Hercules-participant fearful-of-a-congressional-investigation quote in 1983 press) describes the March 24 1965 Chloracne Problem Meeting his affidavit concedes he attended, so it corroborates rather than contradicts. The six Frawley sentences in 565 F Supp 1263 re-confirmed verbatim across independent renderings. NOT TESTABLE for the document the claim names first: the July 3 1963 Frawley-to-Rowe letter has never been digitized or independently read (DocumentCloud, Poison Papers, ToxicDocs, UCSF IDL, USDA NAL all miss); its only characterization is Frawleys own affidavit, accepted by the court but read oppositely by plaintiffs as evidence of pre-1965 2,4,5-T knowledge. Consistency with the 1963 letter therefore rests circularly on the affiants self-description of a document no third party can read. Counter-lead (does not refute): Bleiberg et al Arch Dermatol 89:793-7 (June 1964) put 2,4,5-T-production chloracne in the open literature pre-1965 but concerns a different (Diamond Alkali Newark) plant and names neither Frawley nor Hercules. Net: true wherever Frawleys own documents are readable, but one named document is structurally unverifiable and carries a contrary reading, so a blanket consistent cannot be fully sustained, matching the dossiers own hedge (no proven inconsistency; 1963 letter unresolvable).",
  "caveats": "The 1963 letter is the decisive gap: not digitized, never independently read, only self-characterized by the affiant, read oppositely by plaintiffs. The 1965 Doc B wording reaches us only via secondary paraphrase chained to 1983 NYT/UPI reporting (no recoverable exhibit/Bates), though its substance maps onto the verified March 1965 meeting. The dioxin-free and no-chloracne-1961-1970 prongs are self-sourced (Hercules own testing/affidavit), uncontradicted but not independently corroborated (1991 NIOSH Dioxin Registry not read). DocumentCloud metadata renders John F Frawley, an OCR variant of John P Frawley; company and role match. Decisive primaries remain sealed under PTO 43 (96 FRD 582), likely at NARA New York City RG 21 MDL 381. Local files: /mnt/data/Frawley/06_ANALYTIC_MEMO.md; /mnt/data/Frawley/_workflow_results/acq_10_565_F._Supp._1263_verbat.json; /mnt/data/Frawley/03_DOCUMENT_REGISTER.md."
}